JP Morgan Chase’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Buy
+563,800
New +$2.94M ﹤0.01% 3912
2023
Q4
Sell
-254,700
Closed -$1.39M 7742
2023
Q3
$1.39M Sell
254,700
-1,929,100
-88% -$15.5M ﹤0.01% 3840
2023
Q2
$20.2M Sell
2,183,800
-319,600
-13% -$2.7M ﹤0.01% 1692
2023
Q1
$20.6M Buy
2,503,400
+709,200
+40% +$7.83M ﹤0.01% 1641
2022
Q4
$20M Sell
1,794,200
-1,164,600
-39% -$13.5M ﹤0.01% 1681
2022
Q3
$35.1M Buy
+2,958,800
New +$44.8M 0.01% 1227
2021
Q4
Sell
-124,700
Closed -$2.5M 6839
2021
Q3
$2.5M Buy
+124,700
New +$2.56M ﹤0.01% 3602

Other funds holding MPT

JP Morgan Chase's MPT Position: Q1 2026 in Review

JP Morgan Chase reduced its Medical Properties Trust (MPT) stake by 16% in Q1 2026, selling an estimated $1.53M and leaving 1,511,657 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3018.

JP Morgan Chase first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.8M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • JP Morgan Chase held 1,511,657 shares of Medical Properties Trust worth $6.89M as of Q1 2026.
  • JP Morgan Chase sold 294,244 Medical Properties Trust shares in Q1 2026, an estimated $1.53M.
  • Medical Properties Trust made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3018 holding.
  • JP Morgan Chase first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Medical Properties Trust position peaked at $83.8M in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.